期刊
JOURNAL OF MOLECULAR NEUROSCIENCE
卷 38, 期 2, 页码 85-93出版社
HUMANA PRESS INC
DOI: 10.1007/s12031-007-9004-z
关键词
Amyotrophic lateral sclerosis; mRNA; Gene array; Apolipoprotein E; Cathepsin; EGFR; LYST
资金
- National Parkinson Foundation, Miami, FL, USA
- Norma and Alan Aufzein Chair for Research in Parkinson's disease, Tel Aviv University, Israel
- Scientific and Technical Cooperation Austria-Israel [III/7 1999]
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by loss of motor neurons in the cerebral cortex, brain stem, and spinal cord. Most cases (90%) are classified as sporadic ALS (sALS). The remainder 10% are inherited and referred to as familial ALS, and 2% of instances are due to mutations in Cu/Zn superoxide dismutase (SOD1). Using cDNA microarray on postmortem spinal cord specimens of four sALS patients compared to four age-matched nonneurological controls, we found major changes in the expression of mRNA in 60 genes including increase of cathepsin B and cathepsin D (by the factors 2 and 2.3, respectively), apolipoprotein E (Apo E; factor 4.2), epidermal growth factor receptor (factor 10), ferritin (factor 2), and lysosomal trafficking regulator (factor 10). The increase in the expression of these genes was verified by quantitative reverse transcriptase polymerase chain reaction. Further analysis of these genes in hSOD1-G93A transgenic mice revealed increase in the expression in parallel with the deterioration of motor functions quantified by means of rotorod performance. The comparability of the findings in sALS patients and in the hSOD1-G93A transgenic mouse model suggests that the examined genes may play a specific role in the pathogenesis of ALS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据